Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03032796
Other study ID # 1R21MH110743-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date March 2020

Study information

Verified date June 2020
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary goal of this project is to evidence potential synergistic benefits on cognitive control processes using a video game ("Body-Brain Trainer", or BBT) that integrates cognitive and physical challenges in a complimentary fashion. Healthy adults will be recruited for a longitudinal experiment and randomly assigned to one of four study groups to mechanistically tease apart the possible presence of any synergistic effects on cognitive abilities through the combination of cognitive & physical challenges.


Description:

Cognitive control functions (e.g. attention, working memory, goal-management) dictate our ability to learn and accomplish selected behavioral goals, with deficiencies in these processes found in a range of mental illnesses. The primary goal of this project is to evidence potential synergistic benefits on cognitive control processes using a video game ("Body-Brain Trainer", or BBT) that integrates cognitive and physical challenges in a complimentary fashion. Healthy adults will be recruited for a longitudinal experiment and randomly assigned to one of four study groups: 1) BBT, 2) "Brain Training" (BBT played with a gamepad controller), 3) "Body Training" (BBT without any cognitive demands), and 4) an expectancy matched placebo control group. Individuals will engage in eight weeks of training within our Neuroscape Laboratory, with pre- and post-training assessments evaluating physical, cognitive, and neural measures. The completion of this project will result in a more sophisticated understanding of how the integration of cognitive and physical training potentially impacts cognitive control processes, setting the stage for more effective interventions for mental illness and learning-related impairments.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date March 2020
Est. primary completion date March 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 55 Years to 80 Years
Eligibility Inclusion Criteria:

- Can walk briskly for at least 15 minutes continuously without stopping

- Can stand up from a chair without using your hands

- Available to come 3x/week to our UCSF Mission Bay laboratory for 8 weeks

- Willing and able to undergo MRI, EEG procedures

- English fluency

Exclusion Criteria:

- cardiac problems

- bypass surgery

- pacemaker or heart valve replacement

- stroke

- respiratory conditions

- head trauma with loss of consciousness for less than a few minutes

- severe head trauma with loss of consciousness for more than a few minutes

- high/low blood pressure

- kidney failure

- electroconvulsive therapy (ECT)

- seizures

- implanted electrodes

- cancer/chemotherapy/radiation

- diabetes

- irritable bowel syndrome

- back problems

- claustrophobia

- Having been diagnosed with a psychiatric or neurological disorder

- Use of an assistive device (e.g., cane or walker) at any time to assist with ambulation

- Joint problems causing significant pain upon movement

- Heart Disease or Cardiovascular Disease

- Respiratory Disease (Lung Disease)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Body-Brain Trainer
A novel video game-based intervention that incorporates i) adaptive algorithms critical for cognitive training, ii) physiological measures such as heart rate into the core game mechanics, and iii) motion capture technology to incorporate whole-body kinematics into game play. This group will train for 36 minutes per day, 3 days a week for 8 weeks.
Body Trainer
A novel video game-based intervention that incorporates physiological measures such as heart rate into the core game mechanics, with motion capture technology to incorporate whole-body kinematics into game play. This group will train for 36 minutes per day, 3 days a week for 8 weeks. The "Body Trainer" group will train using closed-loop adaptive algorithms to challenge physical performance as guided by heart rate, such that the amount of movement needed to respond on each task will dynamically change depending upon the participant being below/above a predetermined derived level of exertion. During "Body Training", participants will only perform a basic reaction task in each level/module to ensure only the most minimal cognitive challenge is present
Brain Trainer
The "Brain Trainer" group will train using the aforementioned closed-loop adaptive algorithms to challenge cognitive performance, except while sitting down and playing with an Xbox control pad (thus removing all physical training aspects). This group will train for 36 minutes per day, 3 days a week for 8 weeks.
Expectancy Matched Control
The placebo-matched control group will engage in a battery of three apps (playing each app 10 minutes per day, 5 days a week for 8 weeks completed in the laboratory that we believe will have no significant impact on the cognitive or physical fitness measures we are assessing: i) an app with 100 different logic games of varying difficulty and length, ii) a language-learning app with 10 language options, and iii) an app that offers a guided Tai Chi program. We have pre-determined that this approach generates matched expectancy compared to our training groups: we asked 100 naïve individuals to predict how they would expect to improve performance on our outcome measures after training on one of these platforms, revealing that placebo training generates equivalent expectations of improvement across each outcome measure as the BBT group.

Locations

Country Name City State
United States UCSF Neuroscape San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Blood Pressure measures Assessing a change in systolic & diastolic pressure following the intervention Before and following the intervention (1 week after intervention use has ended)
Other VO2max Assessing a change in VO2max following the intervention Before and following the intervention (1 week after intervention use has ended)
Other MRI Structural measurement Assessing a change in structural profiles following the intervention Before and following the intervention (1 week after intervention use has ended)
Other MRI functional activity Assessing a change in functional activation profiles following the intervention Before and following the intervention (1 week after intervention use has ended)
Other EEG functional measures (event-related potentials) Assessing a change in event-related potentials following the intervention Before and following the intervention (1 week after intervention use has ended)
Other EEG functional measure (event-related spectral perturbation) Assessing a change in event-related spectral perturbation following the intervention Before and following the intervention (1 week after intervention use has ended)
Other EEG functional measure (long-range coherence) Assessing a change in coherence following the intervention Before and following the intervention (1 week after intervention use has ended)
Primary Test of Variables of Attention (T.O.V.A.) A change from baseline regarding measurement of sustained attention and impulsivity abilities At baseline and following the intervention (1 week after intervention use has ended)
Secondary Delayed Recognition Working Memory Task A change from baseline regarding measurement of working memory abilities in the presence of interference At baseline and following the intervention (1 week after intervention use has ended)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04677920 - The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology N/A
Active, not recruiting NCT03312920 - Investigating Memory Retrieval Improvement in Healthy Subjects N/A
Completed NCT03309072 - Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task N/A
Completed NCT03289832 - Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin N/A
Enrolling by invitation NCT06133530 - Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica N/A
Completed NCT05141903 - Dietary Supplement With and Without a Probiotic and/or Antibiotic
Completed NCT01689259 - Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults Phase 1
Completed NCT01187875 - Resistant Starch and Satiety Phase 0
Completed NCT03312699 - Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort Phase 1
Completed NCT03319134 - Investigating the Neural Correlates in Memory Retrieval After HD-tDCS N/A
Recruiting NCT04104360 - Galacto-oligosaccharides and Intestinal Activity N/A
Completed NCT03228693 - Gene Expression and Biomarker Profiling of Keloid Skin N/A
Completed NCT04146532 - Aspirin Effects on Emotional Reactions Early Phase 1
Completed NCT04206293 - A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers N/A
Recruiting NCT06011018 - Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke N/A
Completed NCT05093205 - STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS Phase 1
Completed NCT04596709 - Investigation of Blood Glucose and Insulin Response After Intake of Vitalose N/A
Completed NCT04272450 - Respiratory Muscle Strength in Different Age Groups
Completed NCT02044679 - Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions N/A
Completed NCT01402973 - Pilot Study of a Dietary Intervention Based Upon Advanced Glycation End Products N/A